erythromycin has been researched along with Adenomatous Polyposis Coli in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beer, G; Brazowski, E; Caspi, M; Cohen, S; Fliss-Isakov, N; Kariv, R; Rosin-Arbesfeld, R; Rosner, G; Shor, Y; Shorer, Y | 1 |
| Alexander, DP; Becker, JM | 1 |
2 trial(s) available for erythromycin and Adenomatous Polyposis Coli
| Article | Year |
|---|---|
Resorting the function of the colorectal cancer gatekeeper adenomatous polyposis coli.
Topics: Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Administration, Oral; Adolescent; Adult; Aged; Child; Codon, Nonsense; Codon, Terminator; Colonoscopy; Erythromycin; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Transcription, Genetic; Treatment Outcome | 2020 |
Colectomy, mucosal proctectomy, and ileal pouch-anal anastomosis. A prospective trial of optimal antibiotic management.
Topics: Adenomatous Polyposis Coli; Administration, Oral; Adult; Anal Canal; Anastomosis, Surgical; Cefoxitin; Colectomy; Colitis, Ulcerative; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Gardner Syndrome; Humans; Ileum; Infection Control; Infusions, Intravenous; Male; Neomycin; Postoperative Care; Postoperative Complications; Premedication; Prospective Studies; Rectum | 1991 |